Last reviewed · How we verify
NCT06951724
Coronary Aspiration Catheter Clinical Trial
NA trial testing Aspiration Catheter in ST-segment Elevation Myocardial Infarction (STEMI) in 144 participants. Currently enrolling.
20 February 2026
Quick facts
| Lead sponsor | BrosMed Medical Co., Ltd |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 144 |
| Start date | 20 February 2025 |
| Primary completion | 20 February 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Aspiration Catheter
- Export Advance Aspiration Catheter
Conditions studied
- ST-segment Elevation Myocardial Infarction (STEMI) — all drugs for ST-segment Elevation Myocardial Infarction (STEMI) →
Sponsor
BrosMed Medical Co., Ltd
Who can join
Adults 18 to 80, any sex, with ST-segment Elevation Myocardial Infarction (STEMI). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluation of the efficacy and safety of an aspiration catheter in patients undergoing PCI for acute ST-segment elevation myocardial infarction (STEMI).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06951724
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aspiration Catheter
Trials testing the same drug.
- NCT03753061 — Intracranial Thrombosis Aspiration Catheter for Recanalization in Acute Ischemic Stroke Therapy (RECOVER) · NA · unknown
Other recruiting trials for ST-segment Elevation Myocardial Infarction (STEMI)
Currently open trials in the same condition.
- NCT06769256 — Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden · Phase 4 · recruiting
- NCT06385834 — The Effect of Morning vs Evening Aerobic Exercise Training on Cardiac Remodeling and Function Improvement in Patients Af · NA · recruiting
- NCT05510661 — Use of Export in Primary Percutaneous Coronary Intervention · NA · active not recruiting
- NCT06586424 — The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Eleva · recruiting
- NCT05709626 — PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction · Phase 4 · recruiting
Other BrosMed Medical Co., Ltd trials
Trials by the same sponsor.
- NCT07187128 — A Post-Market Study of Drug-Coated Peripheral Balloon Dilatation Catheter in Treating Femoropopliteal Artery Stenosis or · NA · not yet recruiting
- NCT07010094 — BM Shockwave Devices Clinical Study in Coronary Calcified Lesions · NA · recruiting
- NCT06214754 — Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI · NA · completed
- NCT05747287 — Evaluate Safety and Efficacy of Pronavi Microcatheter for Use in Endovascular Interventions · NA · completed
- NCT05998252 — Evaluate Safety and Efficacy of Alveo HP Balloon Dilatation Catheter for Balloon Dilatation of Coronary Artery Stenosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06951724 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BrosMed Medical Co., Ltd
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06951724.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing